Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 3/2016

Ausgabe 3/2016

Inhaltsverzeichnis ( 10 Artikel )

01.03.2016 | Review | Ausgabe 3/2016

Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic

Kinga Majchrzak, Michelle H. Nelson, Stefanie R. Bailey, Jacob S. Bowers, Xue-Zhong Yu, Mark P. Rubinstein, Richard A. Himes, Chrystal M. Paulos

01.03.2016 | Original Article | Ausgabe 3/2016

Identification of the murine H-2Db and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes

Shiwen Peng, Austin Mattox, Simon R. Best, Anca M. Barbu, James A. Burns, Belinda Akpeng, Jessica Jeang, Benjamin Yang, Eiichi Ishida, Chien-Fu Hung, Tzyy-Choou Wu, Sara I. Pai

01.03.2016 | Original Article | Ausgabe 3/2016

The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib

Annkristin Heine, Judith Schilling, Barbara Grünwald, Achim Krüger, Heidrun Gevensleben, Stefanie Andrea Erika Held, Natalio Garbi, Christian Kurts, Peter Brossart, Percy Knolle, Linda Diehl, Bastian Höchst

01.03.2016 | Original Article | Ausgabe 3/2016

Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells

David Palesch, Johanna Wagner, Annika Meid, Nicole Molenda, Marcin Sienczyk, Jutta Burkhardt, Jan Münch, Lea Prokop, Stefan Stevanovic, Mike-Andrew Westhoff, Marc-Eric Halatsch, Christian Rainer Wirtz, Michal Zimecki, Timo Burster

01.03.2016 | Original Article | Ausgabe 3/2016

TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors

Timothy T. Spear, Glenda G. Callender, Jeffrey J. Roszkowski, Kelly M. Moxley, Patricia E. Simms, Kendra C. Foley, David C. Murray, Gina M. Scurti, Mingli Li, Justin T. Thomas, Alexander Langerman, Elizabeth Garrett-Mayer, Yi Zhang, Michael I. Nishimura

01.03.2016 | Original Article | Ausgabe 3/2016

Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155

Baofu Zhang, Weina Zhao, Huizhong Li, Yuanyuan Chen, Hui Tian, Liantao Li, Longzhen Zhang, Chao Gao, Junnian Zheng

01.03.2016 | Original Article | Ausgabe 3/2016 Open Access

The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity

Daphné Laubreton, Sylvie Bay, Christine Sedlik, Cécile Artaud, Christelle Ganneau, Edith Dériaud, Sophie Viel, Anne-Laure Puaux, Sebastian Amigorena, Catherine Gérard, Richard Lo-Man, Claude Leclerc

01.03.2016 | Original Article | Ausgabe 3/2016 Open Access

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity

Kalijn F. Bol, Erik H. J. G. Aarntzen, Jeanette M. Pots, Michel A. M. Olde Nordkamp, Mandy W. M. M. van de Rakt, Nicole M. Scharenborg, Annemiek J. de Boer, Tom G. M. van Oorschot, Sandra A. J. Croockewit, Willeke A. M. Blokx, Wim J. G. Oyen, Otto C. Boerman, Roel D. M. Mus, Michelle M. van Rossum, Chantal A. A. van der Graaf, Cornelis J. A. Punt, Gosse J. Adema, Carl G. Figdor, I. Jolanda M. de Vries, Gerty Schreibelt

01.03.2016 | Original Article | Ausgabe 3/2016

Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model

Toshihiro Suzuki, Hidehiro Kishimoto, Ryo Abe

01.03.2016 | Original Article | Ausgabe 3/2016

Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway

Davide Bommarito, Allison Martin, Edouard Forcade, Maria-Dorothea Nastke, Jerome Ritz, Roberto Bellucci

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise